Free Trial

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 16.35 -0.85 (-4.94%)
As of 10:34 AM Eastern

BVC vs. TSTL, SPEC, AKR, CNSL, ODX, CTEC, AMS, APH, FARN, and HZD

Should you be buying BATM Advanced Communications stock or one of its competitors? The main competitors of BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Alliance Pharma (APH), Faron Pharmaceuticals Oy (FARN), and Horizon Discovery Group plc (HZD.L) (HZD). These companies are all part of the "medical" sector.

BATM Advanced Communications vs. Its Competitors

BATM Advanced Communications (LON:BVC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, community ranking, risk and valuation.

42.4% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 50.4% of Tristel shares are owned by institutional investors. 26.2% of BATM Advanced Communications shares are owned by company insiders. Comparatively, 4.9% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

BATM Advanced Communications received 42 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.10% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
BATM Advanced CommunicationsOutperform Votes
190
49.10%
Underperform Votes
197
50.90%
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%

Tristel has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£130.32M0.67-£278.26K-£0.04-379.57
Tristel£42.24M4.30£6.54M£13.6627.81

Tristel has a net margin of 15.47% compared to BATM Advanced Communications' net margin of -0.21%. Tristel's return on equity of 20.43% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.21% -0.22% 0.58%
Tristel 15.47%20.43%9.89%

In the previous week, Tristel's average media sentiment score of 1.11 beat BATM Advanced Communications' score of 0.00 indicating that Tristel is being referred to more favorably in the news media.

Company Overall Sentiment
BATM Advanced Communications Neutral
Tristel Positive

BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 6.1%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.4%. BATM Advanced Communications pays out -2,321.5% of its earnings in the form of a dividend. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. BATM Advanced Communications is clearly the better dividend stock, given its higher yield and lower payout ratio.

BATM Advanced Communications has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500.

Summary

Tristel beats BATM Advanced Communications on 10 of the 16 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£86.82M£3.61B£5.59B£2.92B
Dividend Yield3.52%1.99%5.28%4.90%
P/E Ratio-379.5719.0927.12125.92
Price / Sales0.67527.71419.48243,053.68
Price / Cash2.12146.5438.2528.07
Price / Book0.703.017.104.62
Net Income-£278.26K£99.80M£3.23B£5.91B
7 Day Performance-1.87%0.91%2.45%6.80%
1 Month Performance4.14%2.63%8.65%16.55%
1 Year Performance-8.66%116.30%31.26%78.04%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 16.35
-4.9%
N/A-1.2%£86.82M£130.32M-379.57980Gap Up
TSTL
Tristel
N/AGBX 373
+6.6%
N/A-13.7%£178.18M£42.24M27.30208Positive News
SPEC
INSPECS Group
N/AGBX 48
flat
N/A-22.1%£48.80M£195.14M-11.881,673
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.35
+4.7%
N/A-25.0%£7.97M£9.77M-362.103,200Gap Down
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
N/AGBX 292.80
-0.1%
GBX 301.67
+3.0%
+17.9%£7.45B£2.71B49.3110,000
AMS
Advanced Medical Solutions Group
2.7035 of 5 stars
GBX 217.50
+1.2%
GBX 300
+37.9%
+0.0%£469.64M£132.18M42.1510News Coverage
Positive News
APH
Alliance Pharma
2.0148 of 5 stars
GBX 64.70
flat
GBX 6,250
+9,560.0%
N/A£350.32M£183.50M-10.4391,000
FARN
Faron Pharmaceuticals Oy
N/AGBX 235
+4.4%
N/A+147.7%£315.49MN/A-6.2934
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416

Related Companies and Tools


This page (LON:BVC) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners